Background
On the morning of February 9, 2026, a delegation from the Cuban biopharmaceutical sector led by Ambassador Milena Caridad Zaldívar Piedra and Dr. Pedro Camilo Rodríguez Rodríguez, head of business development at BIOCUBAFARMA, met with H.E. Dr. Ngov Kang, Secretary of State of Cambodia’s Ministry of Health. The meeting took place at the Ministry of Health headquarters in Phnom Penh.
Key Provisions or Decisions
The parties discussed opportunities to promote business models and cooperation for the import and use of Cuban biopharmaceutical products in Cambodia. The focus was on treatments for cancer and diabetes, aligned with Cambodia’s healthcare needs and priorities. Emphasis was placed on ensuring the quality, safety, and effectiveness of these products in compliance with international regulatory standards.
Implications for Investors, Businesses, or Compliance
This dialogue signals potential expansion of Cambodia’s pharmaceutical sources to include Cuban biopharmaceutical products, which may impact pharmaceutical import policies and healthcare service offerings. Stakeholders in the health and pharmaceutical sectors should note this emerging cooperation for possible future partnerships and compliance requirements.
Official Source
https://www.facebook.com/MinistryofHealthofCambodia/posts/pfbid0BhUxnBixzTJyU1cHFhLFLZc7mCnPYNzwGkhrEwz9A1ZBfZiQAr5N3ei5LELhZNK6l
